<DOC>
	<DOCNO>NCT02493374</DOCNO>
	<brief_summary>This study people type 2 diabetes high cholesterol age 18 65 . This study try figure partial bypass small intestine reverse type 2 diabetes people require cholesterol lower tolerate statin drug .</brief_summary>
	<brief_title>Mitigation Type 2 Diabetes Partial Ileal Bypass</brief_title>
	<detailed_description>The partial ileal bypass ( PIB ) operation standard procedure use management hyperlipidmia since 1963 . POSCH intervention modality National Institutes Health , National Heart Lung Blood Institute-funded Program Surgical Control Hyperlipidemias ( POSCH ) trial . The POSCH study secondary trial patient document prior myocardial infarction . The trial compare post-dietary lipid therapy change 421 PIB-intervention patient 417 control , lower total plasma cholesterol 24 % ( P &lt; 0.0001 ) , lower low density lipoprotein ( LDL ) -cholesterol 38 % ( P &lt; 0.0001 ) , elevation high density lipoprotein ( HDL ) -cholesterol 4 % ( P=0.02 ) . These lipid change associate 35 % ( P &lt; 0.001 ) reduction intervention group death due coronary heart disease confirm recurrent myocardial infarction , well 27 % ( P &lt; 0.038 ) reduction peripheral vascular disease , 54 % ( P &lt; 0.005 ) diminution occurrence coronary artery surgery angioplasty . Concurrently clinical study , POSCH assess sequential coronary arteriogram 0 , 3 , 5 , 7 , 10 year , show less disease progression surgery group , even statistically significant plaque regression PIB cohort . POSCH PIB patient exhibit statistically significant increase life expectancy ; find persist 25-year follow-up assessment . In field metabolic/bariatric surgery , resolution type 2 diabetes gastrointestinal tract manipulation clearly demonstrated 1998 . In three meta-analyses , procedure involve shorten ileum ( biliopancreatic diversion duodenal switch ) responsible high percentage type 2 diabetes resolution . Recently evaluation standard metabolic/bariatric experimental metabolic operation engender type 2 diabetes resolution minimal weight loss non-obese diabetic patient . The gut-diabetes relationship often attribute increased elaboration hormone glucagon-like peptide-1 ( GLP-1 ) peptide YY ( PYY ) , secrete L-cells intestinal mucosa . These hormone seem work concert , either elicit metabolic response augment action . With respect pancreatic endocrine function , GLP-1 PYY contribute incretin effect , counteract insulin depression action gastrin stimulate peptide gastrin-releasing peptide , stimulate glucose-dependent insulin secretion , preinsulin gene expression , beta-cell proliferation , antiapoptopic pathway . It show GLP-1 secretion reduce patient type 2 diabetes . In recent study effect direct human terminal ileum cecal contact food hydrolysate , significant plasma GLP-1 PYY elevation demonstrate , confirm ability cecum , well ileum , secrete GLP-1 PYY stimulation . In Goto-Kakizaki rat naturally occur type 2 diabetes , ileal bypass excision lower GLP-1 production , interestingly increase five- six-fold . These complementary study give rise hypothesis : PIB operation , addition action cholesterol metabolism , may aslo prevent resolve type 2 diabetes . In laboratory University Minnesota , investigator clearly establish mechanism reduction total cholesterol LDL-cholesterol PIB : interference cholesterol bile acid enterohepatic cycle , markedly decreased absorption reabsorption cholesterol bile acid , increase excretion cholesterol bile acid , increase turnover cholesterol generate bile acid replenish cholesterol pool , insufficient ability body ( even familial hypercholesterolemics ) maintain miscible ( plasma liver ) less-freely miscible ( tissue , include artery ) body pool , , thereby , depletion cholesterol content atherosclerotic plaque . investigator ( see ) add knowledge elimination terminal ileum intestinal pathway increase circulate GLP-1 level , incretin probably emanate cecum . The investigator complete submit publication study incidence type 2 diabetes POSCH program 25 plus year formal trial closure ( IRB Code Number : 1408M53283 ) . The title paper `` Partial Ileal Bypass Affords Protection Onset Type 2 Diabetes '' . Of 66 control patient responder POSCH , 17 contract type 2 diabetes ( 25.8 % ) ; 80 PIB responder , 8 contract type 2 diabetes ( 10 % ) . The difference group significant ( P=0.015 Fisher Exact Test ) odds ratio 0.320 PIB group two-fold ( 2.6 ) increase incidence type 2 diabetes control . Including borderline type 2 diabetes ( prediabetic ) patient , value 22 66 control ( 33.3 % ) 10 80 PIB patient ( 12.5 % ) , odds ratio 0.286 P &lt; 0.004 , two-fold ( 2.7 ) increase incidence type 2 diabetes control patient . Therefore , PIB appear afford protection onset type 2 diabetes 30 year .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Hyperlipidemia patient refer partial ileal bypass , also type 2 diabetes . Preoperative Cpeptide indicative nonfunctioning islet cell .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>